scholarly journals Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study

ESMO Open ◽  
2021 ◽  
Vol 6 (4) ◽  
pp. 100191
Author(s):  
K. Hotta ◽  
S. Saeki ◽  
M. Yamaguchi ◽  
D. Harada ◽  
A. Bessho ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Mutant

Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)

Lung Cancer ◽  
2020 ◽  
Vol 150 ◽  
pp. 62-69
Author(s):  
Rosario Garcia-Campelo ◽  
Oscar Arrieta ◽  
Bartomeu Massuti ◽  
Delvys Rodriguez-Abreu ◽  
Ana Laura Ortega Granados ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Randomized Phase Ii ◽  
Egfr Mutant

Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer

Lung Cancer ◽  
2008 ◽  
Vol 60 (3) ◽  
pp. 374-380 ◽  
Author(s):  
Christian Peschel ◽  
Joerg T. Hartmann ◽  
Alexander Schmittel ◽  
Carsten Bokemeyer ◽  
Folker Schneller ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
Pretreated Patients
Sign in / Sign up

Export Citation Format

Share Document